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Following interaction with cognate antigens, B cells undergo cell activation, proliferation,
and differentiation. Ligation of the B cell receptor (BCR) leads to the phosphorylation
of BCR-associated signaling proteins within minutes of antigen binding, a process
with profound consequences for the fate of the cells and development of effector
immunity. Phosphoflow allows a rapid evaluation of various signaling pathways in
complex heterogenous cell subsets. This novel technique was used in combination
with multi-chromatic flow cytometry (FC) and fluorescent-cell barcoding (FCB) to study
phosphorylation of BCR-associated signaling pathways in naïve and memory human
B cell subsets. Proteins of the initiation (Syk), propagation (Btk, Akt), and integration
(p38MAPK and Erk1/2) signaling units were studied. Switched memory (Sm) CD27+ and
Sm CD27− phosphorylation patterns were similar when stimulated with anti-IgA or -IgG.
In contrast, naïve and unswitched memory (Um) cells showed significant differences
following IgM stimulation. Enhanced phosphorylation of Syk was observed in Um cells,
suggesting a lower activation threshold. This is likely the result of higher amounts of IgM
on the cell surface, higher pan-Syk levels, and enhanced susceptibility to phosphatase
inhibition. All other signaling proteins evaluated also showed some degree of enhanced
phosphorylation in Um cells. Furthermore, both the phospholipase C-γ2 (PLC-γ2) and
phosphatidylinositol 3-kinase (PI3K) pathways were activated in Um cells, while only
the PI3K pathway was activated on naïve cells. Um cells were the only ones that
activated signaling pathways when stimulated with fluorescently labeled S. Typhi and
S. pneumoniae. Finally, simultaneous evaluation of signaling proteins at the single cell
level (multiphosphorylated cells) revealed that interaction with gram positive and negative
bacteria resulted in complex and diverse signaling patterns. Phosphoflow holds great
potential to accelerate vaccine development by identifying signaling profiles in good/poor
responders.
Keywords: naïve B cells, IgM memory B cells, cell signaling, phosphoflow, fluorescent-cell barcoding, Salmonella
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INTRODUCTION
The main receptor on the surface of B cells is the B cell recep-
tor (BCR), which is composed of a membrane immunoglobulin
(Ig) and an Igα/Igβ heterodimer (Defranco, 1997; Schamel and
Reth, 2000). The BCR is responsible for antigen binding and sig-
naling and plays a central role in determining the fate of B cells
during their developmental process and later when naïve cells
encounter foreign antigens. In naïve B cells, ligation of the BCR
by cognate antigens initiates a series of responses/signal cas-
cades that will induce cells to proliferate and differentiate, which
will ultimately lead to the production of antibodies specific for
the pathogenic microorganism (Benschop and Cambier, 1999).
Therefore, signaling pathways associated with the BCR are crucial
for B cell development, activation, proliferation, differentiation
(e.g., memory and plasma B cells) and apoptosis (Defranco, 1997;
Benschop and Cambier, 1999; Dal Porto et al., 2004).
The signaling pathways associated with the BCR are com-
plex and involve multiple molecules which can be divided into
small units for simplicity: (1) signal initiation unit, which involves
early events associated with the BCR-complex itself; (2) signal
propagation unit, which involves signal amplification and diver-
sification of the BCR, via key effector and adaptor molecules that
lead to downstream effectors and the production of second mes-
senger molecules; (3) signal integration unit, which involves the
pathways by which these downstream effectors/second messen-
gers regulate transcription factor activation and therefore gene
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expression [reviewed in: Dal Porto et al. (2004); Kurosaki (1999,
2000, 2011); Gold (2002); Defranco (1997)]. In the signal ini-
tiation unit, engagement of BCR by antigens allows tyrosine
phosphorylation of the intracellular Igα/Igβ immunoreceptor
tyrosine-based activation motifs (ITAMs) by Src-family kinases,
such as Lyn, leading in turn to the activation of the spleen tyro-
sine kinase (Syk) (Takata et al., 1994; Lankester and Van Lier,
1996; Defranco, 1997; Kurosaki, 1999; Dal Porto et al., 2004).
This initiates assembly of the signalosome (signal propagation
unit), composed of a variety of intracellular signaling molecules,
such as Vav, Btk, phosphatidylinositol 3-kinase (PI3K), and phos-
pholipase C-γ2 (PLC-γ2) (Kurosaki, 1999; Dal Porto et al., 2004;
Scharenberg et al., 2007), as well as adaptor proteins, such as B
cell linker (BLNK) and B cell adaptor for PI3K (BCAP) (Goitsuka
et al., 1998; Okada et al., 2000). These adaptors proteins have
served to identify two main BCR-associated signaling cascades:
(1) PLC-γ2 and (2) PI3K pathways. In the PLC-γ2 pathway, BCR
stimulation leads to phosphorylation of Igα/Igβ ITAMs, followed
by Syk recruitment and activation (phosphorylation). Activated
Syk, phosphorylates BLNK (Ishiai et al., 1999a,b), allowing the
binding of PLC-γ2 and Btk. PLC-γ2 becomes activated by Syk
and Btk to produce diacylglycerol (DAG) and inositol-1,4,5-
triphosphate (IP3) from phosphatidylinositol-4,5-bisphosphate
(PIP2), leading to release of intracellular Ca2+, activation of
Ca2+-release activated Ca2+ channels (CRAC) and extracellular
Ca2+ influx (Baba et al., 2001; Tomlinson et al., 2001). In the PI3K
pathway, after BCR stimulation, CD19 is phosphorylated by Lyn,
and BCAP is phosphorylated by Syk and Btk. Phosphorylated
CD19 or BCAP activates PI3K to produce phosphatidylinosi-
tol (3,4,5)-trisphosphate (PIP3) from PIP2, and the resultant
PIP3 transmits signals downstream, including the activation of
Akt and therefore activation of the cell survival pathway (Okada
et al., 2000; Koyasu, 2003; Cuni et al., 2004). An important
aspect of the BCR signaling is the connection between intracel-
lular signaling pathways with activation of transcription factors
and regulation of gene expression in the nucleus (signal inte-
gration unit). A primary integration point of BCR signaling is
the mitogen activated protein kinase (MAPK) family, consisting
of three members: extracellular signal-regulated kinase (ERK),
c-Jun N-terminal kinase (JNK/SAPK), and p38MAPK (Dong
et al., 2002; Johnson and Lapadat, 2002). Following activation,
these kinases phosphorylate different sets of transcription fac-
tors including (1) E twenty-six (ETS)-like transcription factor
1 (Elk-1) and c-Myc by ERK, (2) c-Jun and activating transcrip-
tion factor 2 (ATF-2) by JNK, and (3) ATF-2 and myc-associated
factor X (MAX) by p38MAPK. The BCR is connected to these
“downstream” effectors by a “phosphorelay” system of cyto-
plasmic kinases which phosphorylate and regulate each other
(Johnson and Lapadat, 2002). In summary, BCR ligation leads
to activation of its signaling pathways, which triggers a variety of
intracellular processes and concludes with phenotypic and geno-
typic modifications defining the B cell response to the triggering
stimulus.
Immunological memory is a very effective mechanism devel-
oped by the immune system to ensure rapid protection against
infections (Tangye and Tarlinton, 2009) and critical for long-
term protection elicited by vaccination (Levine and Sztein, 2004).
The phenotypic analysis of human B cell subpopulations by flow
cytometry (FC) using the IgD/CD27 classification scheme, cur-
rently accepted by most investigators, leads to the identification
of four populations: (1) naïve [IgD+CD27−], (2) unswitched
memory (Um) [CD27+IgD+], (3) switched memory CD27+
(Sm CD27+) [CD27+IgD−], and (4) switched memory CD27−
(Sm CD27−) [CD27−IgD−] B cells (Sanz et al., 2008; Pauli
et al., 2011). Some of these populations have been associated with
pathogenic conditions. For example, the recently described Sm
CD27− B cells are more abundant in patients with active SLE
and in patients with RVS infection (Fecteau et al., 2006; Wei
et al., 2007; Sanz et al., 2008). Um B cells, also known as mem-
ory IgM B cells, are important for protection against encapsulated
bacteria [e.g., S. pneumoniae and N. gonorrhea (So et al., 2012;
Kruetzmann et al., 2003)] and involved in T-cell independent
immune responses (Weller et al., 2004). Interestingly, these cells
have been suggested to be a different population of innate or naïve
B cells, but not a true memory B (BM) population. Therefore,
despite the progress made in understanding naïve and BM cell
subpopulations, considerable gaps in knowledge remain. It has
become clear that there is a big heterogeneity in the B cell com-
partment and our pre-conceived notions of function, as well as
cellular and anatomical origin, need to be explored in further
detail.
The study of BCR-associated signaling pathways has grown
exponentially during the last decade, but still relies largely on
traditional biochemical methods (e.g., western blots, ELISA).
Additionally, most of the published literature relies on estab-
lished cell lines [e.g., DT40 (Takata et al., 1995; Lindvall and
Islam, 2002)], cell transfected with different B cell signaling
molecules [e.g., drosophila S2 (Rolli et al., 2002)], or mouse mod-
els (Su et al., 2002; Srinivasan et al., 2009; Young et al., 2009;
Woyach et al., 2012). Despite the usefulness of these method-
ologies and models, there are limitations, including the difficulty
on translating the results to humans and the study phospho-
rylation patterns at the single cell level which will enable the
investigation of signaling pathways in individual cell subsets. Due
to relatively large number of cells required to perform tradi-
tional assays and the difficulty to sort cells without altering their
signaling profile, the study of BCR-associated signaling path-
ways in human B cell subpopulations and individual cells has
proven challenging. The use of fluorescently labeled monoclonal
antibodies for specific phosphorylated epitopes and the develop-
ment of advanced multichromatic FC techniques have allowed
the development of a new technology (phosphoflow) for the
study of signaling pathways in primary human cells (Krutzik
and Nolan, 2003; Irish et al., 2006; Schulz et al., 2007; Galligan
et al., 2009; Krutzik et al., 2011b). This novel technology, in
spite of still being in development, has already been used in
clinical studies, particularly in blood cancer research (e.g., lym-
phomas), to identify basic aspects of the cell biology of cancerous
cells and susceptibility to chemotherapeutic agents (Irish et al.,
2004; Nolan, 2006; Chen et al., 2008; Galligan et al., 2009).
However, the potential use of this technology to understand basic
aspects of B cell biology in normal and pathologic conditions
is enormous and has yet to be realized. To begin exploring the
power of this technology to study basic biology and its potential
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usefulness to accelerate vaccine development, we developed a
staining technique that allows identification of naïve and mem-
ory cells using the IgD/CD27 classification scheme and explored
the differences in activation of BCR-associated signaling pathways
in different B cell subpopulations in peripheral blood mononu-
clear cells (PBMC) of healthy volunteers. Our approach involves
the simultaneous measurement of various phosphoproteins and,
to multiplex the technique, we coupled the phosphoflow assay
with fluorescent-cell barcoding (FCB) (Krutzik and Nolan, 2006;
Krutzik et al., 2011a). The results demonstrate the feasibility
of studying cell signaling pathways in B cell subpopulations
by FC at the single cell level and highlights important differ-
ences in the BCR-associated signaling pathways among these cell
subpopulations. Furthermore, the use of fluorescently labeled
bacteria led to the identification of B cell subpopulations that
interact with these bacteria and demonstrated differences in the
signaling profile triggered by gram positive and gram negative
microorganism.
MATERIALS AND METHODS
HUMAN VOLUNTEERS AND ISOLATION OF PERIPHERAL BLOOD
MONONUCLEAR CELLS (PBMC)
PBMC collected from 8 healthy adult volunteers, recruited from
the Baltimore-Washington area and University of Maryland,
Baltimore campus, were used in this study. Written informed
consent was obtained from all volunteers and the procedures
approved by the University of Maryland, Baltimore IRB. PBMC
were isolated immediately after blood draws by density gradi-
ent centrifugation and cryopreserved in liquid nitrogen following
standard techniques (McArthur and Sztein, 2012).
CELL SURFACE STAINING FOR FLOW CYTOMETRY
Cryopreserved PBMC were thawed, allowed to rest overnight
in complete media [RMPI (Gibco, NY, USA) supplemented
with 10% fetal bovine serum (FBS) (Gemini Bioproducts, West
Sacramento, CA), 2mM L-glutamine (Gibco, Grand Island,
NY, USA), 1× non-essential amino acids (Gibco, Grand Island,
NY, USA), 10mM HEPES (Gibco, Grand Island, NY, USA),
2.5mM Sodium pyruvate, (Lonza, Walkersville, MD, USA),
100U/ml Penicillin, 100 ug/ml streptomycin (Sigma-Aldrich,
St. Louis, MO, USA), 50μg/ml Gentamicin (Gibco, Grand
Island, NY, USA)] and stained for FC in V-shaped 96-well
plates using methods previously described (Toapanta and
Ross, 2009; McArthur and Sztein, 2012). Briefly, 1 × 106 cells
were plated and stained for viability using a violet-fixable dye
(Invitrogen, USA). After two washes with FC staining buffer
(4% FCS, 1× phosphate buffered saline (PBS), and 0.02 Sodium
Azide) cells were blocked with mouse IgG (25μl of a 2.0μg/ml
solution in FC buffer) (Meridian Life Sciences, Memphis,
TN, USA) and stained with an antibody cocktail prepared in
FC buffer. Antibodies used included: IgD-FITC (polyclonal
sera goat anti-human; Southern Biotechnologies), IgG-PE
(polyclonal sera goat anti-human; Southern Biotechnologies),
CD19-ECD (clone:J3-119; Beckman Coulter), IgA-Biotin
(polyclonal sera goat anti-human; Southern Biotechnologies),
IgD-APC (clone: IA6-2; Becton Dickinson -BD-), CD27-APC-
Alexa700 (clone: 1A4CD27; Beckman Coulter), and CD3-Pacific
Blue (clone: UCHT1; BD). After washing the cells 2× with
FC buffer, Pacific Orange-Streptavidin was added to each well
(Invitrogen, USA). Stained cells were fixed with 1% PFA in PBS.
LABELING OF BACTERIAWITH Alexa 700 (Ax700)
Wild-type S. Typhi strain Ty2 (Deng et al., 2003) was grown in
LB broth at 37◦C while shaking. S. pneumoniae (ATCC 6303)
was grown in Brain Heart infusion (37◦C, 5% CO2). Bacteria
cells were grown until an OD of 0.8 (600 nm) was reached. Ten
ml of this bacteria culture solution were spin are re-suspended
in 1ml of PBS. Cells were then heat-inactivated for 30min
at 56◦C and then transferred to ice cold water for 2–3min.
Bacteria cells were then washed once in 10ml of PBS (3000 rpm,
4◦C, 15min), the pellet re-suspended in 500μl of an Ax700-
succinimidyl solution (2μg/ml), and stained for 30min on ice
in the dark. Bacteria cells were then washed 2× with 10ml of FC
buffer and then fixed with 1% paraformaldehyde (PFA) in 1× PBS
for 20min on ice in the dark. Cells were washed 2× (FC buffer)
and re-suspended in 1% bovine serum albumin (BSA) at 0.8
OD and stored at 4◦C. Appropriate bacteria staining were con-
firmed by FC using a MoFlo flow cytometer/cell sorter system
(Beckman Coulter, USA). To determine the CFU contained in
0.8 OD suspensions, 10-fold dilution of freshly harvested bac-
teria were plated into LB agar or sheep blood agar plates and
cultured overnight (37◦C for S. Typhi and 37◦C, 5% CO2 for
S. pneumoniae).
PHOSPHOFLOW
Stimulants used in phosphoflow experiments
Cells were stimulated either with goat anti-human IgM, IgG, or
IgA (Southern Biotech, USA) (5μg/ml) polyclonal sera. A mix-
ture of goat anti-IgM, IgD, IgG, IgA (2.5μg/ml each) and 6mM
Hydrogen peroxide (H2O2) was used as a positive stimulation
control and 1% BSA in PBS as a negative stimulation control.
For experiments involving stimulation with bacteria, 50μl of 0.8
OD Ax700 labeled S. Typhi or S. pneumoniae were used (this is
equivalent to a MOI of 100 to 1).
Cell stimulation
PBMC incubated overnight in complete media at 37◦C, 5% CO2
were re-suspended in ice cold 1% BSA, transferred to 12 × 17mm
tubes (50μl containing 5 × 105/sample) and maintained in ice
for 15min. Meanwhile, stimulants (e.g., goat anti-IgM) were pre-
pared freshly in 1% BSA in PBS. Stimulant aliquots (50μl) were
maintained at room temperature and added to the chilled PBMC
and immediately transferred to a water bath (37◦C) for different
time periods. After stimulation, cells were fixed with 25 ul of 10%
PFA at room temperature (10–20min) and washed 2× with FC
buffer.
Staining and fluorescent-cell barcoding
Fixed cells were stained with anti-human IgD-FITC (Southern
Biotech, USA) for 20min on ice in the dark, washed 2×
with FC buffer and permeabilized with 80% ice cold methanol
(600μl) for 20min at −20◦C. In experiments that required
FCB, pacific orange-succinimidyl at different concentrations
were prepared (80 and 400μg/ml); 5 ul of each concentra-
tion was added to methanol permeabilized cells, followed by
Frontiers in Cellular and Infection Microbiology www.frontiersin.org October 2012 | Volume 2 | Article 128 | 3
Toapanta et al. Signaling pathways in human B-cells
395 ul of 1× PBS. Samples were mixed vigorously and allowed
to stain for 45min on ice in the dark, rehydrated, pooled,
and transferred to a fresh 12 × 17mm tube. Cells were directly
rehydrated when FCB was not required. To rehydrate PBMC,
samples were washed 2× with FC buffer. Samples were then
blocked with human IgG (25 ul of a 1mg/ml solution in FC
buffer) (Sigma-Aldrich, St. Louis, MO, USA) for 10min and
then stained with antibody cocktails in FC buffer for 1 h on
ice in the dark. Antibodies in the cocktails included: CD27-PE
(clone: L128; BD), pAKT-S473-Biotin (clone: D9E; Cell Signaling
Technologies), CD20-PerCP-Cy5.5 (clone: H1; BD), p38MAPK-
T180/Y182-Pacific Blue (clone: 36/p38 (pT180/pY182); BD), Syk-
Y352-Alexa647 (clone: 17A/P-ZAP70; BD), Erk1/2-T202/Y204-
Pacific Blue (clone: 20A; BD), p38MAPK-T180/Y182-PE-Cy7
(clone: 36/p38 (pT180/pY182); BD), and/or Btk-Y551-Alexa647
(clone: BtkY551 & ItkY511; BD). Cells were washed 2× with FC
buffer. In panels that needed a secondary staining step, ECD-
Streptavidin (Beckman Coulter) was added, cells incubated on ice
for 30min, and washed 2× in FC buffer. Cells were then fixed
with 1% PFA in 1× PBS/EDTA and samples collected in a custom
LSRII flow cytometer analyzer (Beckton-Dickson, USA). Samples
were analyzed using a FlowJo software package (Tree Star, USA).
Statistical analysis was performed in GraphPad Prism software
(GraphPad Software Inc., USA).
RESULTS
DISTRIBUTION OF NAÏVE AND BM CELL POPULATIONS IN HUMAN
PBMC AND CELL SURFACE IMMUNOGLOBULIN (Ig) ISOTYPE
EXPRESSION
B cells were identified in PBMC of healthy volunteers as CD19+
and CD3− cells. Subsequently, naïve and BM subpopulations
were defined using IgD and CD27 as previously reported (Sanz
et al., 2008). These markers show four distinct populations of
B cells: naïve (IgD+ CD27−), Um (IgD+ CD27+), Sm CD27+
(IgD− CD27+) and Sm CD27− (IgD− CD27−) (Figure 1A). In
PBMC from 8 screened volunteers, naïve B cells were the most
abundant population (mean 71.7%; SE ± 2.4), followed by Um
(mean 15.9%; SE ± 2.7), Sm CD27+ (mean 8.2%; SE ± 1.4)
and Sm CD27− (mean 2.5%; SE ± 0.6) (Figure 1B). Expression
of surface Ig isotypes was evaluated within each of these sub-
populations (Figures 1C,D). Naïve as well as Um cells expressed
both IgM and IgD, while Sm CD27+ and Sm CD27− B cells
FIGURE 1 | Naïve and BM cell subpopulations defined by IgD and CD27
markers in PBMC. Four B cell (CD19+ CD3−) subpopulations are defined by
expression of IgD and CD27: Naïve (IgD+ CD27−), Um (IgD+ CD27+), Sm
CD27+ (IgD− CD27+), and Sm CD27− (IgD− CD27−) (A). The percentages
of these B-cell subpopulations showed little variation in 8 healthy adult
volunteers (B). An example of surface Ig isotype (IgM, IgD, IgA, and IgG)
distribution in B cell subpopulations in a representative volunteer is shown
(C). Dotted lines indicate where the gates were set to determine the
percentage of each Ig class. (D) Compiled data of the percentages of the Ig
isotypes on the surface of each B-cell subpopulation (n = 8).
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expressed mainly IgA and IgG. Interestingly, a small percentage
of Sm CD27+ cells also expressed IgM (mean 17%; SE ± 3)
(Figures 1C,D).
DIFFERENTIAL EXPRESSION OF IgM AND IgD ON THE SURFACE OF
NAÏVE AND Um B CELLS
As described above, similar percentages of naïve and Um B
cells co-expressed IgM and IgD (Figure 1D). However, Um
expressed a higher amount of IgM molecules/cell than naïve
B cells (Figures 1C, 2A,B), as determined by mean fluorescent
intensity (MFI). These differences were statistically significant
(p < 0.0001) (Figure 2B). On average Um B cells expressed
2.6-fold more IgM than naïve B cells (Figure 2B).
NAÏVE AND Um B CELLS SHOW DIFFERENT Syk PHOSPHORYLATION
INTENSITY PATTERNS FOLLOWING BCR STIMULATION
A staining technique that allowed appropriate resolution of naïve
and BM cell subpopulations in conditions suitable to assay phos-
phorylation of signaling proteins was developed (see “Appendix
Figure A1 and Materials and Methods”). To investigate whether
this optimized staining technique allowed the evaluation of phos-
phoproteins associated with the BCR, overnight rested PBMC
were stimulated with goat F (ab’)2 anti-human IgM (5μg/ml)
for 5min. Phosphorylation of Syk (pSyk—Y352), one of the
phosphotyrosine kinases (PTK) associated with the BCR was
then measured in naïve and Um B cells. As expected, Sm
CD27+ and Sm CD27− B cells, most of which are IgM nega-
tive (Figures 1C,D), did not show significant pSyk (Figure 3A).
To further validate this assay, PBMC were stimulated with anti-
IgG and anti-IgA antibodies [goat F (ab’)2 anti-human IgG or
IgA; 5μg/ml; 5min]. Under these conditions pSyk was detected
in Sm CD27+ and Sm CD27− cells, but not in naïve and Um
B cells (Figures 3B,C). In subsequent experiments, FCB, which
provides a unique fluorescent signature to cells in independent
samples and allows flow cytometric multiplexing, was incorpo-
rated in the phosphoflow assay (Figure 4A). FCB enabled the
simultaneous measurement of multiple time points in a sin-
gle tube and provided additional consistency in the staining.
Fluorescent-cell barcoded samples were later deconvoluted for
FIGURE 2 | Naïve and Um B cells show different frequency of IgM
molecules on the cell surface. Um B cells (black line histogram) show a
higher IgM mean fluorescence intensity (MFI) on their surface than naïve
B cells (gray closed histogram) as shown in this representative volunteer
(A). Compiled data from 8 healthy adults (B). ∗∗∗p = 0.0001.
analysis (Figure 4B). Syk phosphorylation (Y352) was examined
in PBMC stimulated with anti-IgM at various time points
(0, 1, 2, 5, 8, 10, 15, 20, and 30min) (Figure 4C). Similar
levels of pSyk were detected in resting naïve and Um B cells
(Figure 4C—0min). Phosphorylation was detected as early as
1min after anti-IgM stimulation and the intensity of pSyk (MFI)
was higher in Um than in naïve B cells at every time point
measured. Furthermore, Um B cells remained phosphorylated
for a longer period of time (Figure 4C). In order to deter-
mine if the differences in Syk phosphorylation were also due
to dissimilar levels of this protein, total levels of Syk were eval-
uated. Um B cells had higher amounts (2-fold) of pan-Syk
(phosphorylated and non-phosphorylated) than naïve B cells
(Figure 4D).
DIVERSE SIGNALING ACTIVATION PATHWAYS IN NAÏVE AND Um
B CELLS
Anti-IgM stimulated PBMC (similar time points as described
before) were assayed for phosphorylation of proteins associ-
ated with the BCR signaling pathways (Syk-Y352, Btk-Y551,
Akt-S473, p38MAPK-T180/Y182, and Erk1/2-T202/Y204) in two
separate panels. These proteins allow the simultaneous eval-
uation of the initiation (Syk), propagation (Btk, Akt), and
integration signaling units (p38MAPK-T180/Y182 and Erk1/2-
T202/Y204). Furthermore, the selected proteins can also provide
some information regarding whether the PLCγ2, PI3K, or both
BCR-associated signaling pathways are activated. All evaluated
proteins showed enhanced phosphorylation in Um B cells when
compared to naïve B cells (Figures 5A–E). As described above,
Syk, which represents a protein from the initiation signaling
subunit, showed higher phosphorylation in Um than in naïve
B cells (Figure 5A). Interestingly, the phosphorylation peak was
FIGURE 3 | Anti-IgM induces specific Syk(Y352) phosphorylation in
naïve and Um B cells. Only Um and Naïve B cells, which co-express IgM
and IgD, showed robust Syk phosphorylation after PBMC stimulation with
anti-IgM (A). Interestingly, a small peak was detected in Sm CD27+ cells,
which probably corresponds to IgM cells present in Sm CD27+ cells
(Figure 1D). No phosphorylation of Syk was detected in Sm CD27− B
cells (A). PBMC were also stimulated with anti-IgA and -IgG (B and C,
respectively). Syk phosphorylation was detected in Sm CD27+ and Sm
CD27−, but not in naïve and Um B cells (B and C).
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FIGURE 4 | Fluorescent-cell barcoding (FCB) and time course of Syk
phosphorylation in naïve and Um B cells. FCB was introduced in the
pacific orange channel (0, 0.4, and 2μg/ml) to enable assay multiplexing of
3 samples at a time (see details in “Materials and Methods”) and collected
samples were deconvoluted for analysis (A). Time course experiments of
PBMC stimulated with anti-IgM showed that both, Um and naïve cells
phosphorylated Syk after BCR stimulation (B); however, Um cells showed
stronger phosphorylation than naïve cells (C). Higher levels of total Syk
molecules are present in Um (black line histogram) than in naïve (gray
histogram) B cells (D). Data is shown for one representative volunteer.
observed at 5min, followed by a slow dephosphorylation slope
(Figures 4B, 5A). Among proteins of the integration subunit,
Btk and Akt were also evaluated. Naïve and Um cells showed an
early peak of Btk phosphorylation (Y551) 1–2min after stimula-
tion, followed by a plateau established around minute 10 which
persisted until the last time point collected (30min). Akt was
phosphorylated in naïve and Um cells; however, it was more
prominent in the latter cells (Figure 5C). Interestingly, two phos-
phorylation peaks were identified, one between minutes 5–8 and
a second one at 15–20min. Following the second peak, pAkt-
S473 levels returned to the resting state in both B cell popula-
tions. Among the proteins of the integration signaling subunit,
p38MAPK (T180/Y182) and Erk1/2 (T202/Y204) were evaluated
(Figures 5D,E). Phosphorylation of both proteins was identified
in Um, but not in naive B cells. Furthermore, phosphorylation of
these proteins also showed a biphasic phase with peaks at 2–3 and
8–10min.
INHIBITION OF PHOSPHATASESBY H2O2 IN NAÏVE AND Um B CELLS
Initiation of antigen receptor signaling not only requires acti-
vation of kinases; most importantly, it requires inhibition of
phosphatases (e.g., Phospho-Tyrosine-Phosphatases), which have
100–1000-times higher turnover rate than kinases. H2O2 is a
universal phosphatase inhibitor, which at high doses induces
phosphorylation of proteins associated with the BCR-signaling
pathway mimicking antigen stimulation (Reth, 2002; Singh et al.,
2005; Tonks, 2005). To determine if phosphatases of naïve and
Um B cells were equally susceptible to inhibition by H2O2 and if
inhibition of these proteins contributed to the enhanced phos-
phorylation detected in Um B cells, PBMC were treated with
6mM H2O2 (in the absence of anti-IgM) or 1% BSA (nega-
tive control of stimulation) (5min; 37◦C). This dose of H2O2
was chosen based on previous reports from Irish et al. (2006)
and our own titration experiments (not shown), which demon-
strated that doses lower than 5mM did not inhibit phosphatases
to the point of inducing spontaneous phosphorylation of pro-
teins associated with the BCR. Phosphorylation of Syk, Akt,
and p38MAPK was subsequently evaluated and detected only in
cells stimulated with H2O2 (Figures 6A,B). Syk and p38MAPK
phosphorylation in Um was more intense than in naïve B
cells (percentage and fold changes over unstimulated controls)
(Figures 6A,B). Interestingly, phosphorylation of Akt was similar
in both populations.
ACTIVATION OF BCR-SIGNALING PATHWAYS IN Sm CD27+ AND Sm
CD27− FOLLOWING BCR STIMULATION AND INHIBITION OF
PHOSPHATASESBY H2O2
Anti-IgA and anti-IgG stimulated PBMCwere evaluated for phos-
phorylation of proteins associated with the BCR (Figures 7, A2)
in Sm CD27+ and Sm CD27− B cells. Syk phosphorylation was
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FIGURE 5 | Time course of signaling proteins and pathways associated
with the BCR in naïve and Um B cells. Two multicolor panels were used to
explore simultaneous phosphorylation of signaling proteins and pathways
associated with the BCR at various time points. The data shown is from one
representative volunteer and is presented as mean fluorescence intensity
(MFI). Um demonstrated enhanced phosphorylation potential for all the
phosphoproteins assayed compared to naïve B cells (A to E) following
anti-IgM stimulation. Interestingly, Um and naïve B cells demonstrated
phosphorylation of Syk, Btk, and Akt (A,B, and C), which suggest that the
PI3K pathway is activated in both cell populations. However, p38MAPK and
pERK1/2 (D and E) are phosphorylated only in the Um subset, suggesting
that the PLC-γ2 pathway is also activated in these cells. Additionally, different
phosphoproteins have different kinetics. For example, the peak of Syk
phosphorylation was detected at 5min after stimulation (A), and then slowly
declined; meanwhile, Akt, p38MAPK, and Erk1/2 showed a biphasic behavior
(C,D, and E), which is also evident, but less prominent in Btk (B).
similar between Sm CD27+ and CD27− B cells following stim-
ulation with anti-IgA (Figure 7A—left panel and Figure A2B);
the phosphorylation peak was detected between 5–10minutes.
Btk phosphorylation induced by anti-IgA increased slowly in Sm
CD27+ and Sm CD27− cells, showing a late peak at 15min. A
quicker dephosphorylation in Sm CD27− B cells was recorded
(Figure 7A—center panel). Anti-IgA induced slightly higher
phosphorylation of Akt in Sm CD27+ cells than Sm CD27−
cells. However, the phosphorylation/dephosphorylation patterns
were similar in both populations (Figure 7B—right panel). In
contrast, anti-IgG stimulation induced similar Syk, Btk, and Akt
phosphorylation intensity and kinetics in both Sm CD27+ and
SmCD27− B cells (Figure 7B and Figure A2C). Phosphorylation
peaks of Syk and Btk were observed at 5min (Figure 7B—left
and center panels), while Akt showed a biphasic phosphorylation
peak (5 and 15min) (Figure 7B—right panel). Phosphorylation
of p38MAPK and Erk1/2 were also evaluated in Sm CD27+
and Sm CD27− B cells following anti-IgA and -IgG stimulation;
however, no phosphorylation was detected in our assay. Finally,
inhibition of phosphatases in Sm CD27+ and Sm CD27− B cells
was also evaluated using 6mM H2O2 as described above. The
results showed that Akt and p38MAPK were similarly phospho-
rylated (Figures 8A,B). Although slight differences were detected
in Syk phosphorylation (Figures 8A,B, left panels) these changes
were not as intense as those detected between naïve and Um B
cells (Figures 6A,B, left panels).
BACTERIA INTERACTION AND SIGNALING INDUCED IN NAÏVE AND
Um B CELLS
Heat-killed S. Typhi (gram negative) and S. pneumoniae (encap-
sulated gram positive) fluorescently labeled with Alexa700
(Figure 9A) were used to stimulate PBMC (MOI 100 to 1) (37◦C;
10min) from healthy volunteers. These bacteria were selected
because they have different antigenic structures and it was of
interest to determine whether they could induce different signal-
ing cascades on B cells. Relatively small populations of B cells
interacting with S. Typhi (0.23%) and S. Pneumoniae (1.9%)
were identified (Figure 9B) and these cells corresponded mainly
to naïve and Um B cells (Figure 9C). A higher percentage of
naïve than Um B cells (ratio 2:1) interacted with both bac-
teria (Figure 9C). Phosphorylation of various B cells signaling
proteins (Syk, Akt, and p38MAPK) was then assayed in these
subpopulations (Figures 10A,B). Even though a higher percent-
age of naïve B cells interacted with both bacteria, these cells
did not show phosphorylation of the assayed proteins (data not
shown). On the other hand, phosphorylation of Syk, Akt, and
p38MAPK was induced in Um B cells by both S. Typhi and
S. pneumoniae (Figures 10A,B). The percentage of phosphory-
lated cells for each protein was consistently higher in cells stim-
ulated with S. Typhi than with S. pneumoniae (Figures 10A,B).
Finally, to better demonstrate the complexity of the signaling
responses induced in Um B cells by bacteria we used this novel
phosphoflow technique to determine the percentage of cells that
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FIGURE 6 | Phosphatases in Um B cells are more susceptible to
inhibition by H2O2. PBMC were treated with 6mM of H2O2 and
phosphorylation of proteins associated with the BCR were measured in
naïve and Um B cells (A and B) after 5min of stimulation at 37◦C. Displayed
are overlaps of unstimulated (1% BSA) (red) and stimulated (H2O2 without
anti-IgM) (purple) naïve B cells (A). Similar data display was used for Um B
cells (B). Shown are percentages (red letter/numbers = negative controls;
purple letter/numbers = H2O2 stimulation) as well as fold changes in mean
fluorescence intensity (MFI) of stimulated compared to unstimulated cells.
Um cells showed enhanced phosphorylation of Syk and p38MAPK (B),
compared to naïve B cells (A). Akt phosphorylation was similar in both cell
populations (A and B).
showed single, double, or triple phosphorylation of the signal-
ing proteins assayed, i.e., whether they are multi-phosphorylated
(Figure 11). We observed, for the first time, the presence of multi-
phosphorylated cells and determined that the signaling responses
were different among cells stimulated with S. Typhi and S. pneu-
moniae. S. Typhi-stimulated cells showed a higher percentage of
Um B cells that phosphorylated the three proteins (18%) assayed,
followed by cells that showed only p38MAPK phosphorylation
(12%) and finally 5% showing Akt and p38MAPK phosphory-
lation (Figure 11B). On the other hand, the percentages of Um
B cells that phosphorylated proteins following S. pneumoniae
stimulation were overall smaller. Um B cells that phosphory-
lated only p38MAPK (7%) were the predominant ones. Around
2% of Um cells showed single (Syk), double (Syk, p38MAPK, or
Akt, p38MAPK) and triple (Syk, Akt, p38MAPK) phosphorylated
proteins (Figure 11C).
DISCUSSION
Traditionally, signaling pathways in B cells have been studied
using established cells lines (e.g., DT40) or cell models trans-
fected with various signaling proteins associated with the BCR
(e.g., drosophila S2 cells). These studies have been complemented
by the use of mouse models (e.g., knock-outs and knock-ins)
and have relied heavily in western-blotting and ELISA tech-
niques (Takata et al., 1995; Rolli et al., 2002; Srinivasan et al.,
2009; Young et al., 2009). Despite the usefulness of these mod-
els/techniques and the invaluable data generated, they present
various limitations including the large number of cells required
for experimental procedures, inability to study low frequency cell
populations, inability to study the phosphorylation of proteins
involved in signaling pathways at the single cell level, and in
FIGURE 7 | Time course of phosphorylation of BCR-associated
signaling proteins in Sm CD27+ and Sm CD27− B cells following
anti-IgA and anti-IgG stimulation. Anti-IgA and anti-IgG stimulated
PBMC were assayed for phosphorylation of Syk, Btk, and Akt (A and
B, respectively) at different time points (1, 2, 5, 8, 10, 15, 20, and
30min).
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FIGURE 8 | Phosphatases in Sm CD27+ and Sm CD27− B cells are
similarly susceptible to inhibition by H2O2. PBMC were treated with
6mM of H2O2 phosphorylation of proteins associated with the BCR were
detected in both, naïve and Um B cells (A and B) after 5min stimulation at
37◦C. Displayed are overlaps of unstimulated (1% BSA) (red) and 6mM of
H2O2 stimulated (without anti-IgM) (purple) naïve and Um B-cells.
Percentage as well as fold changes in MFI (as compared to unstimulated)
are shown. Um cells showed enhanced phosphorylation of Syk and
p38MAPK (B), compared to naïve B cells (A). Akt phosphorylation was
similar in both cell populations (A and B).
some cases the difficulty of translating the results from animal
models to humans. The advent of multi-chromatic FC and avail-
ability of monoclonal antibodies for specific phospho-epitopes
has allowed the development of phosphoflow, a novel technique
that permits the evaluation of multiple phosphorylated epitopes
simultaneously at the single cell level in heterogeneous cell mix-
tures. We have used this powerful emerging technique to study
signaling pathways of activation in naïve and BM cell popula-
tions, in human primary cells, following stimulation of the BCR.
Furthermore, the use of fluorescently labeled bacteria allowed the
identification of B cell subpopulations that interact with bacte-
ria and provided a glimpse at the complex and diverse signaling
pathways activated by gram positive and gram negative bacteria
in primary human cells. These studies have important implica-
tions for vaccine development since they provide a novel platform
that, within a few minutes of in vitro exposure to specific anti-
gens, might identify the signaling pathways elicited in appropriate
B subsets that may lead to the induction of short and long-lived
antibody-producing plasmablasts/plasmocytes and long-term
B memory cells.
Immunological memory is one of the key factors in the devel-
opment of long-lasting immune responses to specific antigens
(Levine and Sztein, 2004; Lanzavecchia et al., 2006; Simon et al.,
2009, 2011; El-Kamary et al., 2010; Ramirez et al., 2012; Wahid
et al., 2012). In the case of the B cell compartment, memory is
generally accepted to be provided by two subpopulations: plasma
cells and BM cells (Sanz et al., 2008). Plasma cells, which produce
antibodies, represent an effector memory cell type. Meanwhile,
BM cells represent a central memory cell type due to their ability
to generate and replenish the plasma cell compartment. However,
this traditional view is changing since important effector and reg-
ulatory functions that might be played by central BM cells (e.g.,
cytokine production, antigen presentation, DC regulation) have
been described (Shimamura et al., 1982; Blair et al., 2010; De Wit
et al., 2010; Lund and Randall, 2010; Biragyn and Lee Chang,
2012). Our knowledge of the early events in B cell activation in
naïve andmemory subpopulations is limited. Understanding how
various ligands activate different signaling pathways is dramati-
cally important since these events will ultimately determine the
cell’s fate [antibody or cytokine production (or both), antigen
presentation, apoptosis, etc.]. Four naïve and BM cell populations
are defined by IgD and CD27 surface markers (naïve, Um, Sm
CD27+, and Sm CD27−) (Figure 1A). Expression of additional
surface markers (e.g., class switched Ig, CD21, CD23, CD1c) as
well as the level of mutations in the Ig V genes for these pop-
ulations have been reported by various groups (Weller et al.,
2004; Fecteau et al., 2006; Tangye and Good, 2007; Pauli et al.,
2011; Wu et al., 2011). However, to our knowledge, no study
has reported similarities/differences in signaling pathways asso-
ciated with BCR activation in these B cell subsets in primary
human cells. These early events are critical for determining the
maturation and differentiation of the activated B cells. To study
BCR-associated signaling pathways, we modified a phosphoflow
technique previously published (Krutzik and Nolan, 2003; Perez
and Nolan, 2006; Schulz et al., 2007; Krutzik et al., 2011b) to
accommodate the expression of molecules that allowed appro-
priate resolution of naïve and BM cell population defined by
IgD and CD27 (Figure A1). Furthermore, the phosphoflow assay
was coupled with FCB for multiplexing (Figure 4A) (Krutzik
and Nolan, 2006; Krutzik et al., 2011a). We demonstrated that
Syk is phosphorylated in naïve and BM cells only when stim-
ulated with antibodies directed to Igs expressed by the specific
sub-population (assay specificity). For example, stimulation of
PBMC with anti-IgM led to Syk phosphorylation only in naïve
and Um B cells, which are the main populations expressing IgM
(Figure 3A). IgM also induced a small peak in Sm CD27+ cells
in some volunteers (Figure 3A), which corresponded to a small
population of IgM expressing cells within Sm CD27+ B cells
(Figure 1D). Conversely, PBMC stimulated either with anti-IgA
or -IgG showed phosphorylation of Syk only in Sm CD27+ and
Sm CD27− populations (Figures 3B,C). However, since IgA and
IgG are expressed in about half of Sm CD27+ and Sm CD27−
(Figure 1D) a dual peak (positive and negative) was shown in
each case (Figures 3B,C). These results demonstrated the speci-
ficity of the assay and the feasibility of this approach to explore
phosphorylation at the single cell level in individual subsets based
on surface expression of defined molecules.
Among the B cell populations defined by IgD and CD27,
naïve and Um B cells co-express IgM and IgD; however, the lat-
ter showed a higher frequency of IgM (Figure 2). This led to
the investigation of whether Um B cells were more suscepti-
ble to Syk phosphorylation (and therefore activation) than naïve
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FIGURE 9 | Fluorescently labeled bacteria bind preferentially to naïve
and Um B cells. Heat-killed S. Typhi (gram negative) and S. pneumoniae
(encapsulated gram positive) bacteria were fluorescently labeled with
Alexa700 (A). Unstained bacteria (red closed histograms) and stained
bacteria (continuous lines) are shown in panel A. PBMC were incubated
with labeled bacteria at a MOI of 100:1 for 10min at 37◦C and the population
of B cells recognizing the bacteria identified (B). A higher percentage of B
cells recognizing S. pneumoniae than S. Typhi (B) was observed. A higher
proportion of naïve than Um B-cell subpopulations was found to interact with
the bacteria (C). B and C show data observed in a representative volunteer.
FIGURE 10 | Bacteria-induced cell signaling in Um B cells. B cells
interacting with fluorescently labeled bacteria were assayed for
phosphorylation of signaling proteins (Syk, Akt, and p38MAPK). Shown are
phosphorylation patterns in Um B cells from a representative volunteer
following stimulation with S. Typhi (A) or S. pneumoniae (B) at the 10min
time point.
B cells, when stimulated with anti-IgM antibodies. As expected
UmB cells showed a stronger phosphorylation of Syk at each time
point evaluated (Figures 4B,C). Furthermore, Um B cells had a
higher total amount of Syk protein (phosphorylated and non-
phosphorylated) (Figure 4D) and their phosphatases were more
susceptible to inhibition by H2O2 (Figure 6). Taken together,
these data suggest that Um B cells have a lower activation thresh-
old than naïve B cells. Subsequent experiments demonstrated that
the differences in Syk phosphorylation between naïve and Um
cells were maintained in the downstream signaling proteins eval-
uated (Akt, p38MAPK, and Erk1/2), since in all instances, except
for Btk, Um cells showed different degrees of higher phosphoryla-
tion (Figure 5). Given that, naïve and Um B cells phosphorylated
Btk and Akt, the PI3K, and survival pathways appear to be acti-
vated in both B cell populations. However, p38MAPK and Erk1/2
were phosphorylated only in Um cells, which suggest that the
PLCγ2 pathway was activated only in these cells.
Um B cells, also known as memory IgM cells, are a contro-
versial population (Tangye and Good, 2007; Seifert and Küppers,
2009). These cells were initially classified as a type of memory
cells due to the expression of CD27. However, these cells are
still present in patients with hyper-IgM syndrome (HIGMS), the
immunodeficiency X-linked lymphoproliferative disease (XLP)
and in common variable immunodeficiency (CVID). HIGMS is
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FIGURE 11 | Multiphosphorylated Um B cells. Whether single or multiple
proteins were phosphorylated simultaneously (A) was evaluated by gating
on Um cells which bound S. Typhi or S. pneumoniae (B and C, respectively).
Multiple tri-dimensional views (rotated on the X axis) from a representative
volunteer are displayed (stimulation with S. pneumoniae for 10min) (A).
Spheres represent individual cells and the colors of the spheres are the result
of combination of primary colors at the origin of each axis [x axis: red (pSyk);
y axis: blue (pAkt); and z axis: green (pp38MAPK)] (A). Percentage of Um B
cells that showed, one, two, or three proteins phosphorylated simultaneously
following stimulation with S. Typhi or S. pneumoniae (B and C, respectively).
the result of mutations in the CD40 or CD40 ligand (CD40L)
genes. XLP results from mutations in the SH2D1A gene, while
CVID from mutations in ICOS. All these disorders result in the
absence of BM and patients do not undergo Ig isotype switch-
ing to produce IgG, IgA, and IgE in response to T cell-dependent
antigens. Additionally, these patients have alterations in germinal
centers (Facchetti et al., 1995; Gulino and Notarangelo, 2003; Ma
et al., 2005, 2006; Warnatz et al., 2006). Finally, various recent
reports have shown that Um B cells are critical for protection
against T cell-independent antigens [e.g., encapsulated bacteria
such as S. pneumoniae and N. gonorrhea (Zandvoort and Timens,
2002; Kruetzmann et al., 2003; So et al., 2012)]. Therefore, the
presence of Um in patients with defects that lead to the absence
of BM (HIGMS, XLP, and CIVD), their importance in protection
against T cell-independent antigens and maturation through ger-
minal center-independent pathways, suggests that these cells are
not a true BM population, but rather a separate population of
innate or naïve B cell (Weller et al., 2004). Based on this and other
evidence, Um B cells have been proposed to be the human equiv-
alent of mice’s marginal zone B cells, which play an important
role in responses to T cell-independent antigens and have a lower
activation threshold (Zandvoort and Timens, 2002; Weller et al.,
2004; Lopes-Carvalho et al., 2005). Our data support this hypoth-
esis since compared to naïve, Um B cells had a lower activation
threshold, which dependent at least on three factors: (1) higher
IgM receptors of the surface, (2) higher total levels of the Syk pro-
tein, and (3) enhanced susceptibility to phosphatase inhibition.
Other factors, such as the absence or presence, or different expres-
sion levels, of co-receptors, can also contribute to further lower
the activation threshold and will be explored in future studies.
PBMC stimulated with anti-IgA and -IgG showed phosphory-
lation of Syk in SmCD27+ and SmCD27−B cells, at similar rates
with both stimulants suggesting that these populations have sim-
ilar activation thresholds. Furthermore, as previously discussed,
unlike naïve and Um B cells, Sm CD27+ and Sm CD27− B
cells showed a positive and negative peak since approximately
50% of the cells within these populations expressed one or
the other Ig. Additionally, the intensity of Syk phosphorylation
was much lower than that induced by anti-IgM in Um B cells
(Figure 5A), which is not surprising since only approximately
half of the cells were expected to respond to stimulation. Syk
phosphorylation activated downstream signaling proteins and
overall, Sm CD27+ and Sm CD27− B cells responded equally
to IgG and IgA stimulation, with only minor differences. Most
notably, Akt showed a slow phosphorylation slope, with a peak
at 15min, when cells were stimulated with anti-IgA (Figure 7A,
central panel). Meanwhile, anti-IgG induced a quick response
(peak at 5min) followed by a shallow dephosphorylation slope
(Figure 7B, central panel). Interestingly, Akt phosphorylation was
bi-phasic, with peaks at 5 and 15min, in Sm CD27+ and Sm
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CD27− cells. A slightly higher phosphorylation intensity of Akt
was detected when anti-IgA was used (Figures 7A right panel
vs. 7B right panel). These data suggest that both stimulants-
induced activation of the survival pathway in these cells. Neither
anti-IgA nor -IgG, induced detectable levels of phosphorylated
p38MAPK nor Erk1/2 (not shown), suggesting that the PLCγ2
pathway was neither activated in Sm CD27+ nor in Sm CD27−
B cells. Overall, Sm CD27+ and Sm CD27− had strong sim-
ilarities in the signaling pathways activated, as well as in the
activation threshold. Additional evidence to further support the
notion that both populations have similar activation thresholds
comes from H2O2 stimulation experiments that resulted in simi-
lar phosphatase inhibition, with the exception of Syk. However,
no Syk phosphorylation differences were identified when anti-
IgA or -IgG were used. Future experiments using other ligands as
well as co-receptor stimulation might provide data to determine
if the differences in the inhibition of phosphatases that control
Syk are important for other stimulants. Finally, a caveat in inter-
preting these experiments is that they might not provide enough
resolution for studying the phosphorylation status of some pro-
teins in Sm CD27+ and Sm CD27− B cell populations, due the
mixed surface Ig expression. In future experiments, modification
to the staining techniques to allow selection of cells expressing
only IgA or IgG most likely will reveal more details of the signal-
ing pathways in these cells and will more finely define the role
of these populations in the development of immune responses to
pathogenic agents or vaccination.
Various reports have shown a prominent role of Um B cells
in protection against encapsulated bacteria. The evidence comes
from the enhanced susceptibility that infants, splenectomized
patients and people affected by CVID have for infections by
S. pneumonia (Kruetzmann et al., 2003). In all these cases Um
B cells are undetectable in blood. Furthermore, various studies
have shown that pneumococcal polysaccharide (PS) vaccines are
poorly immunogenic in young children (infants). As the immune
system in children matures, the immune responses to pneumo-
coccal PS vaccination improve, which correlate with an increase
in the frequency of Um cells in peripheral blood (Kruetzmann
et al., 2003). Recent reports have shown that Um cells also play
an important role in N. gonorrheae (another encapsulated bac-
terium) infections (So et al., 2012). To determine if exposure
to encapsulated bacteria resulted in a preferential activation of
Um cells, PBMC from healthy volunteers were exposed to Alexa
700-labeled heat-killed S. pneumoniae (Gram +) and S. Typhi
(Gram −) bacteria. Surprisingly, S. pneumoniae interacted with
both naïve and Um cells. Of note, a higher percentage of naïve
and not Um B cells (2:1 ratio) interacted with these bacteria
(Figure 9B—bottom panel). These results were similar in PBMC
exposed to S. Typhi; however, a lower percentage of B cells inter-
acted with these bacteria (Figure 9B—middle panel). Of note,
despite the higher percentage of naïve B cells interacting with
both bacteria, no phosphorylation of the assayed proteins (Syk,
Akt, and p38MAPK) was detected in this population (data not
shown). On the other hand, Um B cells that interacted with both
bacteria showed phosphorylation (Figures 10A,B). To study the
patterns of B cell phosphorylation in greater detail, we used a
unique feature of phosphoflow, i.e., its capacity to explore the
activation of multiple signaling pathways simultaneously at the
single cell level. Analogous to the term in widespread use to sig-
nify the production ofmultiple cytokines by single cells, we would
like to propose the use of the term “multiphosphorylated cells” to
indicate the presence of more than one signaling pathway acti-
vated in a single cell. Using this technology, we observed that the
multi-phosphorylated cell patterns induced by S. pneumoniae and
S. Typhi were dramatically different (Figures 11B,C). This is not
surprising since these bacteria have different antigenic structures.
The induction of phosphorylation in Um B cells might be due to
the lower threshold needed to activate these cells. Furthermore,
this supports the idea that Um B cells are indeed a type of innate
B cell. The lack of phosphorylation in naïve B cells does not neces-
sarily indicate that these cells were not responsive to the stimuli.
It is possible that these cells interact with the bacteria by other
receptors which induce signaling through pathways not evaluated
in the current study. Moreover, these results might reflect the fact
that the signaling pathways in naïve B cells are more tightly reg-
ulated and that additional and/or stronger signals are required
for activation. The nature of those additional signals (e.g., sec-
ond messengers such as H2O2 to lower the activation threshold,
cytokines, interaction with other cells of the immune system)
remains to be explored.
Among phosphatase inhibitors, H2O2 has gained attention
lately because BCR-ligand stimulation induces H2O2 produc-
tion and cells use this molecule as a second messenger for signal
transduction and amplification (Reth, 2002). Furthermore, vari-
ous studies have shown that stimulation of B cells through other
receptors might also induce H2O2; for example, LPS, which binds
to toll-like receptors (TLRs) is a well know inducer of reactive
oxygen species (including H2O2) (Deleo et al., 1998; Kawahara
et al., 2001). Moreover, in vivo during the development of an
immune response, B cells most likely receive cell signals by dif-
ferent receptors simultaneously (e.g., BCR, CD40, CD19, TLRs,
etc.). Thus, co-receptor stimulation can lead to enhanced H2O2
production that ultimately will reduce the threshold for B cell
activation. Bacteria have a conglomerate of antigens on the sur-
face; therefore, stimulation of PBMC with S. pneumoniae and
S. Typhi is likely to stimulate several receptors on B cells. The
latter consideration, together with the lower activation thresh-
old of Um B cells as suggested by the higher total Syk levels and
enhanced susceptibility of phosphatases to be inhibited, might all
have contributed to enhance Um activation.
A more detailed account of the receptors stimulated by bacte-
ria remains to be explored. However, it is reasonable to speculate
that TLR4 and CD14 receptors are involved in interaction with
LPS from S. Typhi (Ganley-Leal et al., 2010). TLR4 expression has
been reported to be present at low levels in B cells from healthy
volunteers (Ganley-Leal et al., 2010); however, which B cell sub-
population(s) express these receptors has not been described.
Given the results obtained in our experiments we speculate that
Um B cells are part of a subset of B cells expressing this recep-
tor. LPS-induced signaling through TLR4 requires CD14 and
this receptor also has been reported to be expressed in B cells
(Ziegler-Heitbrock et al., 1994). Therefore, the identification of
cells that phosphorylated only p38MAPK (Figure 11B) suggest
that these Um B cells not only express TLR4 and CD14, but also
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that they are functional. Another innate receptor to consider is
TLR5, which has shown to recognize Salmonella flagellin. Similar
to TLR4, TLR5 can lead to phosphorylation of p38MAPK. Co-
phosphorylation of Syk/Akt/p38MAPK or Akt/p38MAPK sug-
gests that BCRwas involved in the phosphorylation of p38MAPK.
On the other hand, S. pneumoniae is known to contain ligands for
TLR2, TLR4, and TLR9. Among the latter, the first two can lead
to p38MAPK phosphorylation alone, which was the higher pop-
ulation identified among Um B cells (Figure 11C). All other pop-
ulations identified with phosphorylation of Syk, Syk/p38MAPK,
Akt/p38MAPK, or Syk/Akt/p38MAPK indicate that BCR interac-
tion was involved at some level. These results show the complexity
of interaction of bacteria with Um B cells and suggest that var-
ious receptors are involved in the initial interaction with these
microorganisms. More detailed studies are required to further
dissect these complex interactions.
In conclusion, phosphoflow is proving to be an important tool
to understand basic mechanisms in the early process of B cell
activation in primary human cells. In the current study, differ-
ences between BCR-dependent signaling pathways among naïve
and Um cells were highlighted. Future studies will address the
role of co-receptor stimulation in BCR activation (e.g., CD40,
CD19/CD21) and how these cooperate to lower/increase the acti-
vation threshold, activate different pathways or induce different
responses. The current study provided evidence that in healthy
volunteers, naïve and Um B cells are the main subpopulations
interacting with bacteria within minutes of exposure and that dif-
ferent bacteria induce different signaling profiles in Um B cells.
Future studies will address if these signaling profiles are compara-
ble among groups of bacteria (e.g., conserved responses to gram
positive/negative bacteria) and other microorganism (virus, par-
asites, etc.). Phosphoflow holds great potential for future studies
in vaccine development, for example could lead to the identifi-
cation of signaling profiles in good/poor responders and predict
if booster immunizations would be necessary weeks before anti-
body titers could be detected. Additionally, in the development
vaccines to PS could lead to the identification of subpopulations
of B cells that recognize conjugated and unconjugated vaccines
and determine if a particular carrier protein will lead, or not, to
the development of T cell memory. Furthermore, the frequency
and signaling profiles of vaccine/pathogen specific B cells (Um
cells, as well as Sm CD27+ and Sm CD27− populations) can
be assayed in specimens collected from immunized subjects or
exposed to natural infection. In summary, phosphoflow is a pow-
erful technique that can be useful not only to study basic aspects
of cell B cell biology, but also in studies in translational and clin-
ical medicine to forecast responses to immunization and help
improve vaccine design by suggesting which B cell populations
need to be stimulated in order to achieve appropriate immune
responses.
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APPENDIX
DEVELOPMENT OF PANELS FOR RESOLVING B CELL NAÏVE AND
MEMORY SUBPOPULATIONS BY PHOSPHOFLOW
One of the limiting factors in developing phosphoflow assays is
the availability of antibodies that recognize target epitopes after
cell fixation (2% PFA) and permeabilization (>80% methanol).
Exposure of cells to these treatments destroys or dramatically
alters most of the common epitopes (e.g., CD19). A limited
number of clones that allow appropriate resolution of the popu-
lation are available (Cytobank.org) (e.g., CD27-L128, CD20-H1).
Despite this, various limitations remain since antibody clones for
various common epitopes have either not been tested or avail-
able; among these epitopes are those for surface Ig isotypes (e.g.,
IgD, IgM, etc.). In order to develop phosphoflow panels to study
naïve and memory B cell populations, a mixed staining technique
was used. This technique involved staining of selected epitopes
immediately after cell fixation (PFA), but before permeabilization
(methanol). Therefore, antibodies needed to fulfill two character-
istics: (1) appropriate epitope recognition after treatment of the
cells with PFA and (2) resistance of the conjugated fluorochrome
to methanol permeabilization. Various monoclonal antibodies to
human IgD, IgM, IgG, and IgA were tested unsuccessfully using
the mixed technique (PFA/MeOH) (data not shown). However,
polyclonal sera [goat F (ab’)2] anti-human-IgD and –IgM con-
jugated to FITC allowed resolution of naïve and memory B cell
populations similar to normal surface staining (Figures A1A,B)
(see “Materials and Methods” for detailed description of staining
technique).
FIGURE A1 | Evaluation of antibodies for phosphoflow in naïve
and BM cell subpopulations. Example of surface staining for
identification of B cells and their subpopulations. CD19 and CD20
are typically used to define B cell populations (A). Several
monoclonal antibodies were evaluated to define B cells, as well as
naïve and memory B cell subpopulations during the optimization of
the staining technique for phosphoflow. The CD19 marker is lost
when cells are treated for phosphoprotein determinations; however,
CD20 (H1 clone) defines these cells appropriately and therefore was
subsequently used in phosphoflow assays (B). Polyclonal anti-IgD
sera (goat anti-human) used in a two step staining technique (see
“Materials and Methods” for details) provided appropriate resolution
of naïve and memory B cell subpopulations for phosphoflow staining
(B). FSC, forward scatter.
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FIGURE A2 | Time course of phosphorylation of pSyk in Sm CD27+
and Sm CD27− B cells following anti-IgA and anti-IgG stimulation.
PBMC from healthy volunteers were stimulated with either anti-IgA or
anti-IgG and phosphorylation of Syk was evaluated at different time
points (1, 2, 5, 8, 10, 15, 20, and 30min) in Sm CD27+ and Sm
CD27− B cell populations (A). Samples were fluorescently barcoded
for multiplexing. Displayed are detailed histograms of pSyk following
anti-IgA (B) and -IgG (C) at each time point.
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